PGxAI and Sequencing.com Announce Strategic Partnership to Advance Affordable Pharmacogenomics

PALO ALTO, Calif., Aug. 19, 2025 - PGxAI and Sequencing.com announced a strategic partnership to deliver affordable pharmacogenomics at consumer scale. As part of the collaboration, PGxAI will launch pharmacogenomic reports on Sequencing.com.

The initiative focuses on reducing adverse drug reactions and enabling safer prescribing. The announcement cites $150B in excess U.S. healthcare costs tied to ADRs and indicates that pharmacogenomics programs can cut such incidents by >30%. PGxAI’s reports are compatible with common consumer genetic data formats and open new revenue opportunities for genomic laboratories via Sequencing.com.

About PGxAI
PGxAI is an AI-driven precision-medicine company that transforms multi-omics and clinical data into real-time, gene-guided prescribing support for health systems, payors, and life sciences partners.